This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wednesday's Small-Cap Winners & Losers

Critical Therapeutics (CRTX) surged 25% after Merck KGaA affiliate Dey agreed to co-promote two of the Lexington, Mass., biotech's zileuton asthma drugs, one of which is still awaiting approval by the Food and Drug Administration. Critical Therapeutics will additionally help promote one of Dey's drug candidates, should it receive regulatory approval. The deal's financial terms weren't disclosed. Shares were up 45 cents to $2.25.

Evolving Systems (EVOL - Get Report) posted nickel-a-share profits for the fourth quarter -- a 1-cent climb from last year that tops the only analyst's estimate by 2 cents, according to Thomson Financial. Revenue dropped 13% to $8.8 million from a year ago, but this tops the sole target by $300,000. Shares of the Englewood, Colo., technical-software company were up $1.67, or 12.6%, to $1.88.

MedAvant Healthcare Solutions (PILL) plummeted 35.6% after the Norcross, Ga., medical-transaction processor said stockholders' equity sank 17% year over year to $27.4 million in the fourth quarter. Revenue fell 8% to $15.8 million. Losses narrowed to $1.6 million, or 12 cents a share, from 14 cents a share last year, but shares were still off $1.77, at $3.20.

First Consulting Group (FCGI), a Long Beach, Calif., business-services firm, tumbled 23% after posting fourth-quarter profits of $5.1 million, or 19 cents a share, which missed consensus estimates by 2 cents a share even though it reversed a year-ago 41-cent loss. The company also expects first-quarter revenue of between $64 million and $66 million, which misses Street expectations by at least $4.9 million. Shares were down $2.68, to $8.98.

Waste-management company Clean Harbors (CLHB) fell 3 cents short of fourth-quarter per-share estimates despite ratcheting up its profits to 56 cents a share, compared with 43 cents a year ago. The Norwell, Mass., firm was losing $6.15, or 12.1%, to $44.75 in recent trading.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CRTX $0.00 0.00%
EVOL $5.07 0.00%
PILL $26.20 0.00%
SEAC $5.70 0.00%
AAPL $94.02 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs